相关实验视频

Updated: Jul 15, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

对有效的siRNAs进行计算设计和验证,以使瘤性KRAS沉默

Prasanna Srinivasan Ramalingam¹, Sivakumar Arumugam¹

¹Protein Engineering Lab, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, India.

|October 2, 2023

概括

研究人员设计并过了四种小干扰RNA (siRNA),以 KRAS mRNA 为向癌症治疗. 这些siRNAs通过抑制KRAS蛋白转化显示治疗潜力,并可能克服KRAS突变癌症的传递挑战.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物信息学是一种生物信息学.

背景情况:

瘤性KRAS突变是各种癌症的关键驱动因素,包括肺癌,结肠癌,乳腺癌和胰腺管道腺癌.
目前对KRAS突变癌症的治疗策略有限,需要新的方法.
小干扰RNAs (siRNAs) 通过直接准和降解KRAS mRNA来抑制蛋白质翻译,提供了一个有希望的策略.

研究的目的:

使用in silico方法设计和识别潜在的siRNA候选对抗KRAS mRNA.
评估设计的siRNAs对人类Argonaute2蛋白 (hAgo2) 的有效性和结合潜力.
评估已识别的siRNAs对KRAS突变癌症的治疗潜力.

主要方法:

在许多siRNA候选人的in silico选中针对KRAS mRNA.
基于特定标准的siRNA过,包括U,R和A规则,GC含量,二次结构,双重稳定性和抑制效率.
分子对接和正常模式分析,以评估结合亲和力和对 hAgo2 的结构影响.

主要成果:

预测了近17个siRNAs,过到4个强有力的候选者:siRNA8,siRNA11,siRNA12和siRNA17.
分子对接揭示了这些siRNA与Hago2的显著负键能,表明它们之间存在强烈的相互作用.
正常模式分析表明,siRNA结合会诱导hago2中的结构变化,从而支持它们的潜在有效性.

结论:

这四种已识别的siRNAs (siRNA8,siRNA11,siRNA12,siRNA17) 证明了对KRAS mRNA的治疗潜力.
需要进一步的体外和体内研究来确认突变KRAS的特异性和治疗疗效.
新兴的传递系统,如抗体-siRNA合物 (ARCs),可以克服目前在KRAS突变癌症中siRNA疗法的挑战.

关键词:

癌症癌症癌症癌症基因沉默是一种基因沉默.克拉斯 (Kras) 是一个国家.这是一种RNA干扰.siRNA 是一个RNA.

更多相关视频

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

相关概念视频

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...

siRNA - Small Interfering RNAs

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...